Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:43 PM ET 10-Q
Financial Results Innovative Food Holdings Inc IVFH

Innovative Food Holdings Q3 2026 Results: Net Loss of $175K, Loss Narrows

Innovative Food Holdings reported a consolidated net income of $2.03 million for the nine months ended September 30, 2026, a significant recovery from a $2.09 million loss in the prior year period. This improvement was driven by a $1.5 million gain from discontinued operations and a $2.69 million gain on the disposition of assets, despite a decrease in total revenue from $47.3 million to $37.2 million.

Key figure
Net loss $175K
4:43 PM ET 10-Q
Financial Results DiaMedica Therapeutics Inc. DMAC

DiaMedica Therapeutics Q3 2026 Results: Net Loss of $11.3M, Loss Widens

DiaMedica Therapeutics reported a net loss of $31.5 million for the nine months ended September 30, 2026, driven by increased research and development expenses for its lead candidate DM199. The company's cash and marketable securities decreased to $34.9 million from $59.9 million at the end of 2025, reflecting ongoing clinical trial costs for preeclampsia and fetal growth restriction programs.

Key figure
Net loss $11.3M
4:42 PM ET 8-K
Financial Results Laird Superfood, Inc. LSF

Laird Superfood Financial Results

Laird Superfood reported Q3 2026 financial results, featuring a 225% revenue increase to $42.0 million following the acquisitions of Navitas Organics and Terrasoul Superfoods. The company achieved profitability with net income of $1.7 million and Adjusted EBITDA of $2.1 million, driven by acquisition synergies and retail distribution expansion.

Term
Q3 2026

“Q3 was our first full quarter operating Laird Superfood, Navitas Organics, and Terrasoul Superfoods as one platform. Net sales grew 225% to $42.0 million, and Adjusted EBITDA reached $2.1 million as we began capturing synergies. We remain excited by the consumer opportunities in front of us and are increasing our marketing activity to capture and sustain growth from the health and wellness trends that continue to play into the strenghts of our brands. Our new executive team is now in place and, with $17.3 million in cash and no debt, we are well positioned for continued, profitable growth.”

Jason Vieth, Chief Executive Officer
4:42 PM ET 8-K
Loan & Debt Algorhythm Holdings, Inc. RIME

Algorhythm Holdings $2M Debt Financing with Streeterville Capital, LLC

Algorhythm Holdings, Inc. made a voluntary $2.0 million prepayment against its outstanding Secured Pre-Paid Purchase #4 (PPP #4) using restricted cash. The lender, Streeterville Capital, LLC, agreed to waive the standard 110% prepayment premium, reducing the company's total outstanding balance under its securities purchase agreement to approximately $8.14 million.

Value
$2M
Counterparty
Streeterville Capital, LLC
4:42 PM ET 8-K
Financial Results Battalion Oil Corp BATL

Battalion Oil Financial Results

Battalion Oil Corporation reported third quarter 2026 financial results, generating sales volumes of 11,359 Boe/d and total operating revenue of $45.6 million. The company highlighted a significant balance sheet transformation, ending the quarter with $92.1 million in cash and reducing net debt to $70.4 million. Additionally, the company executed a transformative midstream transaction to shift crude transportation from trucking to pipeline, expected to significantly lower gathering costs.

Term
Q3 2026

“Our commitment to operational excellence has shown in our third quarter results. I’m proud of the team and look forward to continued execution”

Daniel Rohling, COO of Battalion
4:42 PM ET Form 4
Insider Selling Cytokinetics Inc CYTK

Cytokinetics Insider B. Lynne Parshall Sells $274K of Stock

B. Lynne Parshall sold 5,000 shares of Cytokinetics Inc at $54.17 to $55.26 a share (average $54.73) in 2 transactions, worth $274K in total on Nov 9, 2026. Shares held after the trade: 5,784 (-30.6%).

Value
$274K
Shares
5,000
Average price
$54.73
Holding change
-30.6%
Trade date
Nov 9, 2026
4:42 PM ET Form 4
Insider Selling Everpure, Inc. P

Everpure Chief Visionary Officer John Colgrove Sells $10.1M of Stock

John Colgrove, Chief Visionary Officer, sold 99,993 shares of Everpure, Inc. at $98.88 to $104.75 a share (average $100.77) in 13 transactions, worth $10.1M in total on Nov 10, 2026. Shares held after the trade: 2,365,007 (-0.1%).

Value
$10.1M
Shares
99,993
Average price
$100.77
Role
Chief Visionary Officer
Holding change
-0.1%
Trade date
Nov 10, 2026
4:42 PM ET Form 4
Insider Selling Immunovant, Inc. IMVT

Immunovant Insider Atul Pande Sells $108K of Stock

Atul Pande sold 3,000 shares of Immunovant, Inc. at $36.00 a share, worth $108K in total on Nov 11, 2026. Shares held after the trade: 116,731 (-2.5%).

Value
$108K
Shares
3,000
Price
$36.00
Holding change
-2.5%
Trade date
Nov 11, 2026
4:42 PM ET 10-Q
Financial Results American Battery Materials, Inc. BLTH

American Battery Materials Q3 2026 Results: Net Loss of $901K, Loss Narrows

American Battery Materials Inc. reported a net loss of $6.09 million for the nine months ended September 30, 2026, driven by significant non-cash expenses related to debt extinguishment and note modifications. The company faces substantial liquidity challenges with a working capital deficit of $13.3 million and only $1,465 in cash, leading to an expressed doubt about its ability to continue as a going concern.

Key figure
Net loss $901K
4:42 PM ET 8-K
M&A Deal Mountain Crest Acquisition Corp. V MCAG

Mountain Crest Acquisition Corp. V M&A Deal with CubeBio Co., Ltd.

Shareholders of Mountain Crest Acquisition Corp. V approved the definitive business combination agreement with South Korea-based CubeBio Co., Ltd. The transaction will result in both companies becoming subsidiaries of a new entity, VIANIQ Holdings Limited (formerly CubeBio Holdings Limited). The approval marks a major step toward completing the merger and taking the combined entity public.

Counterparty
CubeBio Co., Ltd.
4:41 PM ET Form 4
Insider Selling Tutor Perini Corp TPC

Tutor Perini Insider Dale Anne Reiss Sells $831K of Stock

Dale Anne Reiss sold 8,881 shares of Tutor Perini Corp at $93.00 to $94.09 a share (average $93.57) in 2 transactions, worth $831K in total on Nov 9, 2026. Shares held after the trade: 26,982 (-13.5%).

Value
$831K
Shares
8,881
Average price
$93.57
Holding change
-13.5%
Trade date
Nov 9, 2026
4:41 PM ET 8-K
M&A Deal Rallybio Corp RLYB

Rallybio M&A Deal with Avenzo Therapeutics, Inc.

Rallybio Corp announced that its pending merger with Avenzo Therapeutics is expected to close following the close of trading on November 20, 2026. The company also provided a timeline update for its previously announced special cash distribution of $13.90 per share, which will be paid to stockholders of record as of November 5, 2026, following Nasdaq due bill procedures.

Counterparty
Avenzo Therapeutics, Inc.
4:41 PM ET 10-Q
Financial Results Talphera, Inc. TLPH

Talphera Q3 2026 Results: Net Loss of $4.02M, Loss Narrows

For the nine months ended September 30, 2026, Talphera reported a net loss of $10.9 million, compared to a $10.5 million loss in the prior year period. Operating expenses increased to $12.0 million, driven by higher research and development costs related to the Niyad product candidate, while cash and short-term investments totaled $14.2 million.

Key figure
Net loss $4.02M
4:41 PM ET Form 4
Insider Selling Everpure, Inc. P

Everpure CEO Charles H. Giancarlo Sells $7.05M of Stock

Charles H. Giancarlo, CEO, sold 70,000 shares of Everpure, Inc. at $98.93 to $104.64 a share (average $100.77) in 7 transactions, worth $7.05M in total on Nov 10, 2026. Shares held after the trade: 1,369,735 (-0.0%).

Value
$7.05M
Shares
70,000
Average price
$100.77
Role
CEO
Holding change
-0.0%
Trade date
Nov 10, 2026
4:41 PM ET 8-K
Financial Results DiaMedica Therapeutics Inc. DMAC

DiaMedica Therapeutics Financial Results

DiaMedica Therapeutics reported Q3 2026 financial results and provided clinical updates on its DM199 programs. The company completed enrollment in the first two cohorts of its Phase 2 fetal growth restriction (FGR) trial and surpassed the 200-participant enrollment threshold for its ReMEDy2 Phase 2/3 acute ischemic stroke trial, with an interim analysis expected in Q1 2027.

Term
Q3 2026

“During the third quarter and recent weeks, we continued to advance DM199 across each of our clinical programs, including completing enrollment in the first two cohorts of our Phase 2 early-onset fetal growth restriction study and reaching the 200-participant enrollment threshold for the planned interim analysis of ReMEDy2.”

Rick Pauls, President and Chief Executive Officer

“Our clinical programs are providing important opportunities to evaluate the pharmacologic effects of DM199 across pregnancy-related vascular disorders and acute ischemic stroke.”

Julie Krop, MD, Chief Medical Officer
4:41 PM ET 8-K
Other 8-K Filing Mountain Crest Acquisition Corp. V MCAG

Mountain Crest Acquisition Corp. V Other 8-K Filing

Mountain Crest Acquisition Corp. V stockholders approved an amendment to the company's charter to extend the deadline for completing an initial business combination to May 16, 2027. In connection with the vote, stockholders redeemed 64,297 shares of common stock.

Term
through May 16, 2027
4:40 PM ET Form 4
Insider Buying Ecolab Inc. ECL

Ecolab Insider David MacLennan Buys $185K of Stock

David MacLennan bought 600 shares of Ecolab Inc. at $308.12 a share, worth $185K in total on Nov 12, 2026. Shares held after the trade: 26,225 (+2.3%).

Value
$185K
Shares
600
Price
$308.12
Holding change
+2.3%
Trade date
Nov 12, 2026
4:40 PM ET 8-K/A
Other 8-K Filing Sidus Space Inc. SIDU

Sidus Space Other 8-K Filing

Sidus Space announced that its financial statements for the fiscal years 2024 and 2025, along with several quarterly reports through mid-2026, should no longer be relied upon. The company intends to restate these affected financial statements in a comprehensive amendment to its 2025 Annual Report and its Q3 2026 Quarterly Report. This non-reliance determination was made by the Audit Committee and management due to identified accounting errors.

4:40 PM ET 10-Q
Financial Results CapsoVision, Inc CV

CapsoVision Q3 2026 Results: Net Loss of $7.34M, Loss Narrows

CapsoVision reported a net revenue of $10.0 million for the nine months ended September 30, 2026, a slight increase from $9.6 million in the prior year. However, the company experienced a net loss of $21.9 million during this period, driven by high research and development expenses as they pursue FDA clearances for new products like the CapsoCam Colon capsule and AI capabilities.

Key figure
Net loss $7.34M
4:40 PM ET Form 4
Insider Selling Veralto Corp VLTO

Veralto SVP, Water Quality Melissa Kapity Sells $608K of Stock

Melissa Kapity, SVP, Water Quality, sold 5,146 shares of Veralto Corp at $118.06 a share, worth $608K in total on Nov 10, 2026. Shares held after the trade: 14,715 (-25.9%).

Value
$608K
Shares
5,146
Price
$118.06
Role
SVP, Water Quality
Holding change
-25.9%
Trade date
Nov 10, 2026
4:39 PM ET Form 4
Insider Selling Magnite, Inc. MGNI

Magnite CLO Aaron Saltz Sells $276K of Stock

Aaron Saltz, CLO, sold 9,597 shares of Magnite, Inc. at $28.75 a share, worth $276K in total on Nov 9, 2026. Shares held after the trade: 214,792 (-4.3%).

Value
$276K
Shares
9,597
Price
$28.75
Role
CLO
Holding change
-4.3%
Trade date
Nov 9, 2026
4:39 PM ET 10-Q
Financial Results T1 Energy Inc. TE

T1 Energy Q3 2026 Results: Net Loss of $40.6M, Loss Narrows

T1 Energy Inc. reported a significant increase in total net sales to $624.4 million for the nine months ended September 30, 2026, driven largely by related party transactions. Despite the revenue growth, the company incurred a net loss of $104.5 million for the period, though this was an improvement from the $178.7 million loss in the prior year.

Key figure
Net loss $40.6M
4:39 PM ET 10-Q
Financial Results Blackstone Private Credit Fund BCRED

Blackstone Private Credit Fund Q3 2026 Results: Net Income $704M, Down 12.5% YoY

As of September 30, 2026, Blackstone Private Credit Fund reported total assets of $79.1 billion and total net assets of $41.1 billion, reflecting a decrease from $47.6 billion at year-end 2025. The fund's investment portfolio is primarily composed of non-controlled/non-affiliated investments valued at $71.3 billion, supported by $34.2 billion in debt.

Key figure
Net income $704M · -12.5% YoY
4:39 PM ET 8-K
Financial Results Dillard's, Inc. DDS

Dillard's Financial Results

Dillard's reported Q3 2026 net income of $130.9 million, or $8.38 per share, on total retail sales of $1.418 billion. The company achieved 1% comparable store sales growth and maintained a strong retail gross margin of 45.3%.

Term
Q3 2026

“We achieved 1% sales growth on top of last year’s 3% increase, supporting a strong 45.3% retail gross margin. As we head into the holidays, our stores and dedicated team are ready to welcome and serve our customers.”

William T. Dillard, II, Chief Executive Officer
4:39 PM ET 10-Q
Financial Results Nakamoto Inc. NAKA

Nakamoto Q3 2026 Results: Turns Profitable, Net Income $85.5M

Nakamoto Inc. reported a net income of $85.5 million for the quarter ended September 30, 2026, a significant recovery from an $86.0 million loss in the prior year, primarily driven by a $110.4 million gain on the fair value of digital assets. However, the company faces a year-to-date net loss of $286.2 million due to substantial goodwill impairment and non-operating expenses earlier in the year.

Key figure
Net income $85.5M
4:39 PM ET 10-Q
Financial Results NeuroPace Inc NPCE ▶ Call

NeuroPace Q3 2026 Results: Net Loss of $3.3M, Loss Narrows

NeuroPace reported a decrease in total assets from $105.6 million at the end of 2025 to $94.8 million as of September 30, 2026, primarily driven by a reduction in cash and short-term investments. The company maintains a significant accumulated deficit of $568.6 million and expects to lose its emerging growth company status on December 31, 2026.

Key figure
Net loss $3.3M
4:39 PM ET 8-K
Capital Raise SmartStop Self Storage REIT, Inc. SMA

SmartStop Self Storage REIT Capital Raise of $334M

SmartStop Self Storage REIT entered into forward sale agreements for an aggregate of 9,372,500 shares of common stock at an initial forward price of $35.6125 per share. The offering includes 8,150,000 initial shares and 1,222,500 shares from the full exercise of the underwriters' overallotment option. The company intends to use the net proceeds from the eventual settlement of these agreements to fund pending investments, including a Canadian joint venture and potential acquisitions.

Value
$334M
Term
through Sept 2028
4:39 PM ET Form 4
Insider Selling United Therapeutics Corp UTHR

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.64M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $584.20 to $598.63 a share (average $593.99) in 14 transactions, worth $5.64M in total on Nov 11, 2026. Shares held after the trade: 324,443 (-0.1%).

Value
$5.64M
Shares
9,500
Average price
$593.99
Role
Chairperson & CEO
Holding change
-0.1%
Trade date
Nov 11, 2026
4:39 PM ET Form 4
Insider Selling Amkor Technology, Inc. AMKR

Amkor Technology CFO Megan Faust Sells $35K of Stock

Megan Faust, CFO, sold 1,000 shares of Amkor Technology, Inc. at $35.00 a share, worth $35K in total on Nov 10, 2026. Shares held after the trade: 132,105 (-0.8%).

Value
$35K
Shares
1,000
Price
$35.00
Role
CFO
Holding change
-0.8%
Trade date
Nov 10, 2026
4:38 PM ET 10-Q
Financial Results Gaxos.Ai Inc. GXAI

Gaxos.Ai Q3 2026 Results: Net Loss of $930K, Loss Narrows

GAXOS.AI INC. reported a significant revenue increase to $7.08 million for the nine months ended September 30, 2026, compared to $0.69 million in the prior year, driven by a $1.75 million gain on the sale of gaming assets. Despite the revenue growth, the company incurred a net loss attributable to common shareholders of $2.86 million due to a substantial rise in selling, general, and administrative expenses.

Key figure
Net loss $930K

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.